CellScape

About:

CellScape Corporation is focused on developing a comprehensive non-invasive prenatal genetic test for women.

Website: http://www.cellscapecorp.com

Top Investors: RA Capital Management, XSeed Capital, Zygote Ventures

Description:

CellScape Corporation (formerly Saryna Medical Corp) is a privately funded company headquartered in Newark, California, in the heart of the biotech corridor of the San Francisco Bay Area. The Company has developed whole fetal cell technology to transform prenatal genetic testing using a simple blood test. Their vision is to make comprehensive prenatal genetic testing available to every woman without requiring an invasive procedure that might put the fetus at risk. Their leadership team is accomplished in bringing innovative, cost-effective medical and molecular diagnostics to market.